0.05
-6.00%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Yestar Healthcare Holdings Co
Its shares trade on HKEX under the ticker 2393.HK. It has been listed since 11 October 2013. In the fiscal year to 31 December 2025, it reported revenue of CN¥1.49bn and a net loss of CN¥75.0m. At that date it held total assets of CN¥1.19bn and shareholders' equity of CN¥378.3m.
Yestar Healthcare Holdings Co. Ltd. engages in the provision of investment with interests in the manufacture, distribution, and sale of medial imaging products and other related solutions. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2013-10-11. The firm operates its business through two segments. The Imaging Printing Products segment is engaged in the manufacture and sale of color photographic paper, industrial Non Destructive Testing (NDT) x-ray films and the trading of imaging equipment. The Medical Products and Equipment segment is engaged in the manufacture and sale of medical dry films, medical wet films and dental films and the sale of medical equipment and reagents.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 11 Oct 2013
- Employees
- 1,081
- Website
- yestarcorp.com ↗
Leadership
Pay as last reported
- Mr. Hartono JamesNon-Executive Chairman of the Board, since 2022CN¥3.9m
- Mr. Jinrong QiaoChief Financial Officer, Executive Director, since 2024
- Ms. Changxiang LiaoExecutive DirectorCN¥1.2m
- Mr. Chunlai WangExecutive Director, since 2025
- Mr. Tsz Hin NgaiCompany Secretary
- Mr. Michael KoeswondoIndependent Non-Executive Director
- Mr. Jinsong ZengNon-Executive Independent DirectorCN¥204,000
- Mr. Ziwei ZhaoIndependent Non-Executive Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Yestar Healthcare Holdings Co Ltd has a strong market presence and brand recognition in the healthcare industry.
- The company has a diversified product portfolio, offering a range of medical devices and services.
- Yestar Healthcare has a strong research and development capability, enabling them to continually innovate and introduce new products.
- The company has an extensive distribution network, allowing them to reach a wide customer base.
- Yestar Healthcare has a strong financial position and has consistently achieved revenue growth over the years.
Weaknesses
- Yestar Healthcare relies heavily on a few key markets for its revenue, making it vulnerable to economic fluctuations in those regions.
- The company faces intense competition from other established players in the healthcare industry.
- Yestar Healthcare's profitability margins have been declining due to increasing costs and competitive pricing pressures.
- The company may lack a strong digital presence and lag behind in utilizing technology for operational efficiencies.
Opportunities
- The growing aging population presents a significant opportunity for Yestar Healthcare to expand its market share in elderly care products and services.
- There is an increasing demand for advanced medical technologies and equipment, which the company can capitalize on through product development.
- Yestar Healthcare can explore strategic partnerships or acquisitions to expand its geographic reach and enter new markets.
- Government initiatives promoting healthcare infrastructure development provide opportunities for the company to secure contracts and partnerships.
Threats
- The regulatory environment in the healthcare industry may change, imposing additional compliance requirements and affecting the company's operations.
- Market competition is intensifying, with new entrants and established players offering similar products and services.
- Fluctuations in currency exchange rates can impact the company's financial performance, especially in international markets.
- Technological advancements may render certain products or services obsolete, requiring Yestar Healthcare to continuously innovate and adapt.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.